HomeComparePPL vs PKI

PPL vs PKI: Dividend Comparison 2026

PPL yields 2.90% · PKI yields 0.24%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PPL wins by $840.00 in total portfolio value
10 years
PPL
PPL
● Live price
2.90%
Share price
$38.02
Annual div
$1.10
5Y div CAGR
-35.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$3.89
Full PPL calculator →
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →

Portfolio growth — PPL vs PKI

📍 PPL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPPLPKI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PPL + PKI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PPL pays
PKI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PPL
Annual income on $10K today (after 15% tax)
$246.48/yr
After 10yr DRIP, annual income (after tax)
$3.31/yr
PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
At 15% tax rate, PPL beats the other by $3.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PPL + PKI for your $10,000?

PPL: 50%PKI: 50%
100% PKI50/50100% PPL
Portfolio after 10yr
$20.1K
Annual income
$1.96/yr
Blended yield
0.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PPL right now

PPL
Analyst Ratings
1
Strong
20
Buy
8
Hold
Consensus: Buy
Price Target
$41.00
+7.8% upside vs current
Range: $37.00 — $44.00
Altman Z
1.0
Piotroski
5/9
PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PPL buys
0
PKI buys
0
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PKI▼ Sell$1,001 - $15,0002020-09-23
Donna Shalala🏢 House$PKI▼ Sell$1,001 - $15,0002019-06-24
David Perdue🏛 Senate$PKI▼ Sell$15,001 - $50,0002017-09-14
David Perdue🏛 Senate$PKI▼ Sell$15,001 - $50,0002017-09-14
David Perdue🏛 Senate$PKI▼ Sell$1,001 - $15,0002017-09-12
David Perdue🏛 Senate$PKI▼ Sell$1,001 - $15,0002017-09-12
David Perdue🏛 Senate$PKI▼ Sell$1,001 - $15,0002017-09-11
David Perdue🏛 Senate$PKI▼ Sell$1,001 - $15,0002017-09-11
David Perdue🏛 Senate$PKI▼ Sell$1,001 - $15,0002017-09-08
David Perdue🏛 Senate$PKI▼ Sell$1,001 - $15,0002017-09-08
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPPLPKI
Forward yield2.90%0.24%
Annual dividend / share$1.10$0.28
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-35.3%-50%
Portfolio after 10y$20.6K$19.7K
Annual income after 10y$3.89$0.02
Total dividends collected$534.00$24.00
Payment frequencyquarterlyquarterly
SectorUtilitiesStock
Analyst consensusBuyHold
Analyst price target$41.00$166.57

Year-by-year: PPL vs PKI ($10,000, DRIP)

YearPPL PortfolioPPL Income/yrPKI PortfolioPKI Income/yrGap
1← crossover$10,888$187.62$10,712$12.15+$176.00PPL
2$11,773$123.52$11,468$6.08+$305.00PPL
3$12,678$80.76$12,274$3.04+$404.00PPL
4$13,618$52.59$13,135$1.52+$483.00PPL
5$14,606$34.16$14,055$0.76+$551.00PPL
6$15,650$22.15$15,039$0.38+$611.00PPL
7$16,760$14.35$16,092$0.19+$668.00PPL
8$17,943$9.29$17,218$0.10+$725.00PPL
9$19,205$6.02$18,424$0.05+$781.00PPL
10$20,553$3.89$19,713$0.02+$840.00PPL

PPL vs PKI: Complete Analysis 2026

PPLUtilities

PPL Corporation, a utility holding company, delivers electricity and natural gas in the United States and the United Kingdom. The company operates through two segments: Kentucky Regulated and Pennsylvania Regulated. It serves approximately 429,000 electric and 333,000 natural gas customers in Louisville and adjacent areas in Kentucky; 538,000 electric customers in central, southeastern, and western Kentucky; and 28,000 electric customers in five counties in southwestern Virginia. The company also provides electric services to approximately 1.4 million customers in Pennsylvania; and generates electricity from coal, gas, hydro, and solar sources in Kentucky; and sells wholesale electricity to two municipalities in Kentucky. PPL Corporation was founded in 1920 and is headquartered in Allentown, Pennsylvania.

Full PPL Calculator →

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →
📬

Get this PPL vs PKI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PPL vs SCHDPPL vs JEPIPPL vs OPPL vs KOPPL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.